These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
102 related items for PubMed ID: 24655023
1. The child with difficult to control Congenital Adrenal Hyperplasia: is there a place for continuous subcutaneous hydrocortisone therapy. Hindmarsh PC. Clin Endocrinol (Oxf); 2014 Jul; 81(1):15-8. PubMed ID: 24655023 [Abstract] [Full Text] [Related]
2. Management of altered hydrocortisone pharmacokinetics in a boy with congenital adrenal hyperplasia using a continuous subcutaneous hydrocortisone infusion. Bryan SM, Honour JW, Hindmarsh PC. J Clin Endocrinol Metab; 2009 Sep; 94(9):3477-80. PubMed ID: 19567522 [Abstract] [Full Text] [Related]
3. Continuous subcutaneous hydrocortisone infusion (CSHI) in a young adolescent with congenital adrenal hyperplasia (CAH). Tuli G, Rabbone I, Einaudi S, di Gianni V, Tessaris D, Gioia E, Lala R, Cerutti F. J Pediatr Endocrinol Metab; 2011 Sep; 24(7-8):561-3. PubMed ID: 21932600 [Abstract] [Full Text] [Related]
4. Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia. Merza Z, Rostami-Hodjegan A, Memmott A, Doane A, Ibbotson V, Newell-Price J, Tucker GT, Ross RJ. Clin Endocrinol (Oxf); 2006 Jul; 65(1):45-50. PubMed ID: 16817818 [Abstract] [Full Text] [Related]
5. Flutamide decreases cortisol clearance in patients with congenital adrenal hyperplasia. Charmandari E, Calis KA, Keil MF, Mohassel MR, Remaley A, Merke DP. J Clin Endocrinol Metab; 2002 Jul; 87(7):3197-200. PubMed ID: 12107224 [Abstract] [Full Text] [Related]
6. A Phase 2 Study of Continuous Subcutaneous Hydrocortisone Infusion in Adults With Congenital Adrenal Hyperplasia. Nella AA, Mallappa A, Perritt AF, Gounden V, Kumar P, Sinaii N, Daley LA, Ling A, Liu CY, Soldin SJ, Merke DP. J Clin Endocrinol Metab; 2016 Dec; 101(12):4690-4698. PubMed ID: 27680873 [Abstract] [Full Text] [Related]
7. Gender related differences in glucocorticoid therapy and growth outcomes among pubertal children with 21-hydroxylase deficiency congenital adrenal hyperplasia (CAH). Deslauriers JR, Lenz AM, Root AW, Diamond FB, Bercu BB. J Pediatr Endocrinol Metab; 2012 Dec; 25(9-10):977-81. PubMed ID: 23426829 [Abstract] [Full Text] [Related]
8. Stress dose of hydrocortisone is not beneficial in patients with classic congenital adrenal hyperplasia undergoing short-term, high-intensity exercise. Weise M, Drinkard B, Mehlinger SL, Holzer SM, Eisenhofer G, Charmandari E, Chrousos GP, Merke DP. J Clin Endocrinol Metab; 2004 Aug; 89(8):3679-84. PubMed ID: 15292287 [Abstract] [Full Text] [Related]
9. Long-term use of continuous subcutaneous hydrocortisone infusion therapy in patients with congenital adrenal hyperplasia. Mallappa A, Nella AA, Sinaii N, Rao H, Gounden V, Perritt AF, Kumar P, Ling A, Liu CY, Soldin SJ, Merke DP. Clin Endocrinol (Oxf); 2018 Oct; 89(4):399-407. PubMed ID: 30003563 [Abstract] [Full Text] [Related]
10. Pharmacokinetic/Pharmacodynamic Evaluation of Hydrocortisone Therapy in Pediatric Patients with Congenital Adrenal Hyperplasia. Melin J, Parra-Guillen ZP, Michelet R, Truong T, Huisinga W, Hartung N, Hindmarsh P, Kloft C. J Clin Endocrinol Metab; 2020 Mar 01; 105(3):. PubMed ID: 32052005 [Abstract] [Full Text] [Related]
11. [Adrenal hyperplasia of late onset: optimization of therapy by measuring the circadian variation of serum 17-OH-progesterone]. Contreras P, Rojas A, Vega I. Rev Med Chil; 1989 Jun 01; 116(6):552-7. PubMed ID: 2749040 [Abstract] [Full Text] [Related]
12. [Treatment of hypertensive forms of congenital adrenal hyperplasia]. Turpin G, Heshmati HM, Jambart S, de Gennes JL. Ann Med Interne (Paris); 1983 Jun 01; 134(3):256-8. PubMed ID: 6605107 [Abstract] [Full Text] [Related]
13. Management of the child with congenital adrenal hyperplasia. Hindmarsh PC. Best Pract Res Clin Endocrinol Metab; 2009 Apr 01; 23(2):193-208. PubMed ID: 19500763 [Abstract] [Full Text] [Related]
14. Timing and type of glucocorticoid replacement in adult congenital adrenal hyperplasia. Ross RJ, Rostami-Hodjegan A. Horm Res; 2005 Apr 01; 64 Suppl 2():67-70. PubMed ID: 16286775 [Abstract] [Full Text] [Related]
15. Caregiver knowledge and self-confidence of stress dosing of hydrocortisone in children with congenital adrenal hyperplasia. Fleming LK, Rapp CG, Sloane R. J Pediatr Nurs; 2011 Dec 01; 26(6):e55-60. PubMed ID: 22055384 [Abstract] [Full Text] [Related]
16. Control in congenital adrenal hyperplasia monitored by frequent saliva 17OH-progesterone measurements. Hughes IA, Read GF. Horm Res; 1984 Dec 01; 19(2):77-85. PubMed ID: 6538545 [Abstract] [Full Text] [Related]
17. Effect of ethosuximide on cortisol metabolism in the treatment of congenital adrenal hyperplasia. Yau M, Rao N, Nimkarn S, Vogiatzi M. J Pediatr Endocrinol Metab; 2014 May 01; 27(5-6):549-54. PubMed ID: 24468605 [Abstract] [Full Text] [Related]
18. Treatment with flutamide decreases cortisol clearance: implications for therapy in congenital adrenal hyperplasia. Charmandari E, Johnston A, Honour JW, Brook CG, Hindmarsh PC. J Pediatr Endocrinol Metab; 2002 Apr 01; 15(4):435-9. PubMed ID: 12008691 [Abstract] [Full Text] [Related]
19. The effect of different treatment regimens on hormonal profiles in congenital adrenal hyperplasia. Smith R, Donald RA, Espiner EA, Glatthaar C, Abbott G, Scandrett M. J Clin Endocrinol Metab; 1980 Aug 01; 51(2):230-6. PubMed ID: 6249832 [No Abstract] [Full Text] [Related]
20. Novel strategies for hydrocortisone replacement. Debono M, Price JN, Ross RJ. Best Pract Res Clin Endocrinol Metab; 2009 Apr 01; 23(2):221-32. PubMed ID: 19500765 [Abstract] [Full Text] [Related] Page: [Next] [New Search]